Regulation of plasma LDL: the apoB paradigm
Open Access
- 23 November 2009
- journal article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 118 (5) , 333-339
Abstract
The objectives of this analysis are to re-examine the foundational studies of the in vivo metabolism of plasma LDL (low-density lipoprotein) particles in humans and, based on them, to reconstruct our understanding of the governance of the concentration of plasma LDL and the maintenance of cholesterol homoeostasis in the hepatocyte. We believe that regulation of cholesterol homoeostasis within the hepatocyte is demonstrably more complex than envisioned by the LDL receptor paradigm, the conventional model to explain the regulation of plasma LDL and the fluxes of cholesterol into the liver, a model which was generated in the fibroblast but has never been fully validated in the hepatocyte. We suggest that the LDL receptor paradigm should be reconfigured as the apoB (apolipoprotein B) paradigm, which states that the rate at which LDL particles are produced is at least an important determinant of their concentration in plasma as the rate at which they are cleared from plasma and that secretion of cholesterol within VLDL (very-low-density lipoprotein) particles is an important mechanism of maintaining cholesterol homoeostasis within the hepatocyte. These two paradigms are not mutually exclusive. The LDL receptor paradigm, however, includes only one critical aspect of the regulation of plasma LDL, namely the rate at which LDL particles are cleared through the LDL receptor pathway, but ignores another – the rate at which LDL particles are added to the plasma compartment. The apoB paradigm includes both and points to a different model of how the hepatocyte achieves cholesterol homoeostasis in a complex metabolic environment.Keywords
This publication has 22 references indexed in Scilit:
- LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL ReceptorScience, 2009
- Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADLJournal of Lipid Research, 2009
- The LDL ReceptorArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Effectors of Rapid Homeostatic Responses of Endoplasmic Reticulum Cholesterol and 3-Hydroxy-3-methylglutaryl-CoA ReductaseJournal of Biological Chemistry, 2008
- Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutationJournal of Lipid Research, 2004
- Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope studyAtherosclerosis, 1995
- ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Substrate delivery as a determinant of hepatic apoB secretion.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Regulation of low density lipoprotein receptor activity in primary cultures of human hepatocytes by serum lipoproteinsHepatology, 1986
- Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.Journal of Clinical Investigation, 1982